Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

1.25
Delayed Data
As of Feb 27
 +0.301 / +31.72%
Today’s Change
0.61
Today|||52-Week Range
1.96
+48.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues44.7M164.8M19.3M1.3M
 
 
 
 
 
Depreciation And Amortization1.4M1.7M2.5M3.8M
 
 
 
 
 
 
Operating ExpensesGross Income43.3M------
 
 
General Expenses99.8M129.2M125.8M93.4M
 
 
 
 
 
Research And Development86.3M101.7M91.4M68.5M
 
 
 
 
 
Total Operating Expenses101.1M130.9M128.3M97.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-56.4M33.9M-109.0M-95.9M
 
 
 
 
 
Extraordinary Charge0.000.00-2.6M-8.1M
 
 
 
Interest Expense On Debt3.4M3.8M3.5M3.1M
 
 
 
 
 
Other Expenses900.0K10.0K247.0K-23.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-58.8M30.6M-114.4M-107.0M
 
 
 
 
 
Net Income-58.8M30.6M-114.4M-107.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.6M39.7M43.4M50.9M
 
 
 
 
 
Shares To Calculate EPS Diluted25.6M41.5M43.4M50.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.30$0.74-$2.64-$2.10
 
 
 
 
 
EPS Diluted-$2.30$0.74-$2.64-$2.10
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account